- The inquiry concerns the applicable VAT rate for specific ophthalmic medical devices produced and distributed by ALFA and BETA.
- The products include various eye sprays and drops, all designed for lubrication, hydration, and relief of ocular discomfort, suitable for use with or without contact lenses.
- The products are formulated with ingredients such as liposomes, cross-linked hyaluronic acid, plant extracts, and are often preservative-free to minimize adverse reactions.
- The devices are intended for treating dry eye syndrome, ocular irritation, and for maintaining or restoring the tear film and ocular surface homeostasis.
Source: agenziaentrate.gov.it
Note that this post was (partially) written with the help of AI. It is always useful to review the original source material, and where needed to obtain (local) advice from a specialist.
Latest Posts in "Italy"
- New Anti-Tax Evasion Rules: Digital Payments, POS Obligations, and Stricter Expense Deductions for Businesses
- Faster VAT Collection: 2026 Budget Law Automates Assessments for Omitted Declarations in Italy
- Italy Approves 2026 VAT Return Models
- VAT Measures in Italy’s 2026 Budget Law
- Tax Refunds and Credit Notes: Limited Timeframes and Conditions for Financial Administration













